The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like ...

More than half of all men with Klinefelter syndrome (KS) are unaware that they have the condition. Among those who do receive ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of ...

Sangamo Therapeutics (NASDAQ:SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate isaralgagene civaparvovec, or ST-920, in the treatment of Fabry disease. The ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Some clinical trials have validated a new perspective on continuous renal replacement therapy (CRRT) in combination with oXiris haemofilter to more effectively enhance endotoxins clearance and ...

Transportation Secretary Sean Duffy — the anti-LGBTQ+ former congressman, reality TV personality, and Fox host who replaced former Transportation Secretary Pete Buttigieg — is now saying that ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with a rate reaching almost PH ...

Pediatric patients can receive P510,000 to P765,210 for CAPD and P763,000 to P1.2 million for APD. The package also includes coverage for related services like infection prevention and treatment for ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...